Human Osteoclast Formation and Activity In Vitro: Effects of Alendronate

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Bone and Mineral Research

• Publication date

  1998-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1359/jbmr.1998.13.11.1721PMID 9797481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) on the resorptive function of osteoclasts of known nuclear number

  2004cited by this paper
• Bisphosphonates: mechanisms of action

  1998cited by this paper
• Isolation and culture of osteoclasts and osteoclast resorption assays

  1998cited by this paper
• Effect of alendronate treatment on the osteoclastogenic potential of bone marrow cells in mice.

  1997cited by this paper
• Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone.

  1997cited by this paper
• Osteoclast activation: Potent inhibition by the bisphosphonate alendronate through a nonresorptive mechanism

  1997cited by this paper
• Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.

  1997cited by this paper
• Effect of diacylglycerols on osteoclastic bone resorption

  1996cited by this paper
• Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

  1996cited by this paper
• Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis.

  1996cited by this paper
• Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

  1996cited by this paper
• Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures.

  1996cited by this paper
• The human osteoclast precursor circulates in the monocyte fraction.

  1996influential reference
• Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.

  1996cited by this paper
• Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption.

  1996cited by this paper
• Bisphosphonates: mechanisms of action.

  1996cited by this paper
• Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells.

  1996influential reference
• Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

  1995cited by this paper
• Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

  1995cited by this paper
• A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders.

  1995cited by this paper
• Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin.

  1995cited by this paper
• The effects of bisphosphonates on the resorption cycle of isolated osteoclasts

  1994cited by this paper
• Effects of phorbol myristate acetate on rat and chick osteoclasts

  1992cited by this paper
• An assessment of the ability of human bone marrow cultures to generate osteoclasts.

  1992cited by this paper
• Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

  1991influential reference
• The effects of stimulators of intracellular cyclic AMP on rat and chick osteoclasts in vitro: validation of a simplified light microscope assay of bone resorption.

  1990cited by this paper
• Effects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy

  1990influential reference
• Bone resorption by isolated human osteoclasts in vitro: Effects of calcitonin

  1989influential reference
• Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

  1989cited by this paper
• The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor

  1989cited by this paper
• The multinucleate cells in giant cell granulomas of the jaw are osteoclasts

  1988influential reference
• Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures.

  1987cited by this paper
• A comparative study of disaggregated chick and rat osteoclasts in vitro: effects of calcitonin and prostaglandins.

  1987influential reference
• Biological activity of chicken calcitonin: Effects on neonatal rat and embryonic chick osteoclasts

  1987cited by this paper
• Chicken osteoclasts do not possess calcitonin receptors

  1987cited by this paper
• Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.

  1986cited by this paper
• Calcitonin

  1968cited by this paper

• Alendronate-Functionalized Polycaprolactone/Gelatin Electrospun Fibrous Membranes for Enhanced Osteogenesis and Antiosteoclastogenesis in Bone Regeneration.

  2025cites this paper
• Similarities and Differences between Osteoclast-Mediated Functional Activation of NK, CD3+ T, and γδ T Cells from Humans, Humanized-BLT Mice, and WT Mice.

  2024cites this paper
• Osteoblastgenic and Osteogenic Effects of KY-273 with CDK8/19 Inhibitory Activity in Bone Marrow Mesenchymal Stem Cells and Female Rats.

  2024cites this paper
• Alendronate for Effective Treatment of Male Osteoporosis : An Insight.

  2024cites this paper
• Characterization and quantification of in-vitro equine bone resorption in 3D using μCT and deep learning-aided feature segmentation.

  2024cites this paper
• Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ

  2023cites this paper
• Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies.

  2023cites this paper
• Inhibition of osteoclastogenesis after bisphosphonate therapy discontinuation: an in vitro approach

  2022cites this paper
• An in vitro model for discovery of osteoclast specific biomarkers towards identification of racehorses at risk for catastrophic fractures.

  2022cites this paper
• Effects of Alendronate and Dexamethasone on Osteoclast Gene Expression and Bone Resorption in Mouse Marrow Cultures

  2021cites this paper
• The Effect of Alendronate on Osteoclastogenesis in Different Combinations of M-CSF and RANKL Growth Factors

  2021cites this paper
• Osteoporosis Therapy: Mechanistic Antiresorptives

  2021cites this paper
• ATRAID regulates the action of nitrogen-containing bisphosphonates on bone

  2020cites this paper
• Oral administration of bovine lactoferrin accelerates the healing of fracture in ovariectomized rats

  2020cites this paper
• Hybrid particles derived from alendronate and bioactive glass for treatment of osteoporotic bone defects.

  2019cites this paper
• A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration

  2019cites this paper
• ATRAID, a genetic factor that regulates the clinical action of nitrogen-containing bisphosphonates on bone

  2018cites this paper
• Étude rétrospective de l'efficacité et de la tolérance des bisphosphonates au cours de l'algodystrophie

  2018cites this paper
• A Novel H2S-releasing Amino-Bisphosphonate which combines bone anti-catabolic and anabolic functions

  2017cites this paper
• MiR-142-3p is a RANKL-dependent inducer of cell death in osteoclasts

  2016cites this paper
• The utility of bone scintigraphy in the assessment of mandibular metabolism during long-term bisphosphonate administration

  2016cites this paper
• Gingival epithelial cells support osteoclastogenesis by producing receptor activator of nuclear factor kappa B ligand via protein kinase A signaling.

  2016cites this paper
• Role of Osteoclasts in potential pathogenic mechnism of ONJ

  2015cites this paper
• Role of Osteoclasts in the potential pathogenic mechanism of Osteonecrosis of Jaw

  2015cites this paper
• Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: Role in osteoclast-mediated NK cell activation

  2015cites this paper
• Management of Root Resorption Using Chemical Agents: A Review

  2015cites this paper
• Effects of alendronate on osteoclast formation and activity in vitro.

  2015cites this paper
• Role of Osteoclasts in the potential pathogenic mechanism of Osteonecrosis of Jaw

  2015cites this paper
• Cellular and molecular actions of bisphosphonates

  2015cites this paper
• Investigating In Vivo Efficacy of Novel ALN-EP4a Conjugate Drugs for the Treatment of Post-menopausal Osteoporosis

  2014cites this paper
• Alendronate‐induced atypical bone fracture: evidence that the drug inhibits osteogenesis

  2014cites this paper
• The osteoblast and osteoclast responses to phosphonic acid containing poly(ε-caprolactone) electrospun scaffolds.

  2014cites this paper
• Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss

  2014cites this paper
• Low toxicity and unprecedented anti-osteoclast activity of a simple sulfur-containing gem-bisphosphonate: a comparative study.

  2013cites this paper
• Low concentrations of zoledronic acid are better at regulating bone formation and repair.

  2013cites this paper
• The effect of alendronate on the expression of important cell factors in osteoclasts.

  2013cites this paper
• Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells

  2013cites this paper
• Alendronate

  2012cites this paper
• Influence of Bisphosphonate Treatment on Medullary Macrophages and Osteoclasts: An Experimental Study

  2012influential citation
• Synthesis, characterization and biological activity of hydroxyl-bisphosphonic analogs of bile acids.

  2012cites this paper
• The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells.

  2012cites this paper
• Reduced Osteoclastogenesis and RANKL Expression in Marrow from Women Taking Alendronate

  2011cites this paper
• Investigation of the linkage between Gaucher disease and BCelldisorders including multiple myeloma

  2011cites this paper
• Measurement by vertical scanning profilometry of resorption volume and lacunae depth caused by osteoclasts on dentine slices

  2011cites this paper
• Biochemical and molecular mechanisms of action of bisphosphonates.

  2011cites this paper
• Chapter 49 – SKELETAL MATURATION AND BONE MINERALIZATION IN THE PEDIATRIC RHEUMATIC DISEASES

  2011cites this paper
• Bisphosphonates: the first 40 years.

  2011cites this paper
• A comparison of osteoclast resorption pits on bone with titanium and zirconia surfaces.

  2010cites this paper
• Effects of alendronate and risedronate therapy on hepatic antioxidant enzyme activity and lipid peroxidation in ovariectomized rats

  2010cites this paper
• Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.

  2010cites this paper
• Alendronate induces mineralization in mouse osteoblastic MC3T3-E1 cells: regulation of mineralization-related genes.

  2010cites this paper
• Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor.

  2009cites this paper
• Avaliação microscópica do efeito tópico do alendronato e do fluoreto de sódio na superfície radicular de dentes de ratos extraídos e reimplantados tardiamente

  2009cites this paper
• Effect of monosodium olpadronate on osteoclasts and megakaryocytes: an in vivo study.

  2009cites this paper
• Chapter 81 – Bisphosphonates: Mechanisms of Action

  2008cites this paper
• Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats

  2008cites this paper
• Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.

  2008cites this paper
• Recovery of Trabecular and Cortical Bone Turnover After Discontinuation of Risedronate and Alendronate Therapy in Ovariectomized Rats

  2008cites this paper
• Bone Resorption Inhibitor Alendronate Normalizes the Reduced Bone Thickness of TRPV5−/− Mice

  2008cites this paper
• The Molecular Mechanisms of Action of Bisphosphonates

  2007cites this paper
• The Osteoclast Development in Patients with Rheumatoid Arthritis and the Influence of the Bisphosphonate on Its Development

  2007cites this paper
• Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs.

  2007cites this paper
• A new method for quantitative based on contact surface profi lometry measurement of resorbed bone vo lume

  2007cites this paper
• ÉVALUATION PRECLINIQUE DE NOUVELLES THERAPIES CIBLANT LES OSTEOCLASTES DANS LE TRAITEMENT DES METASTASES OSSEUSES DU CANCER DU SEIN.

  2007cites this paper
• Pharmacokinetic profile of bisphosphonates in the treatment of metabolic bone disorders.

  2007cites this paper
• Molecular Mechanisms of Action of Bisphosphonates: Current Status

  2006cites this paper
• Adsorption of bisphosphonate onto hydroxyapatite using a novel co-precipitation technique for bone growth enhancement.

  2006cites this paper
• Biology of Bone Cancer Pain

  2006cites this paper
• Bisphosphonates

  2006cites this paper
• Les bisphosphonates oraux dans le traitement de l'ostéoporose postménopausique

  2006cites this paper
• 류마티스관절염환자 초혈액단핵구에서 파골세포의 분화 및 분화에 대한 비스포스포네이트의 영향

  2006cites this paper
• Human osteoclast culture from peripheral blood monocytes: phenotypic characterization and quantitation of resorption.

  2005cites this paper
• Effect of Korean Oriental Medicine Extract on Bone Mass as Compared with Alendronate in Ovariectomized Rats

  2005cites this paper
• Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts

  2005cites this paper
• Advances in understanding bone cancer pain

  2005cites this paper
• Alendronate Inhibits Bone Resorption at the Bone-screw Interface

  2005cites this paper
• [Diagnosis and treatment of juvenile osteoporosis].

  2005cites this paper
• Cytotoxicity analysis of alendronate on cultured endothelial cells and subcutaneous tissue. a pilot study.

  2005cites this paper
• Diagnostic et traitement de l'ostéoporose juvénile

  2005cites this paper
• A new method based on contact surface profilometry for quantitative measurement of resorbed bone volume.

  2005cites this paper
• Targeting the Osteoblast for Prevention and Treatment of Bone Diseases

  2004cites this paper
• The Role of Bisphosphonates in Bone Metastasis

  2004cites this paper
• Nitrogen-containing bisphosphonate mechanism of action.

  2004cites this paper
• From Molds and Macrophages to Mevalonate: A Decade of Progress in Understanding the Molecular Mode of Action of Bisphosphonates

  2004cites this paper
• Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis

  2004cites this paper
• Effect of pamidronate on the stimulation of macrophage TNF‐α release by ultra‐high‐molecular‐weight polyethylene particles: a role for apoptosis

  2003cites this paper
• Bisphosphonate mechanism of action.

  2003cites this paper
• The inhibitory effect of alendronate and taurine on osteoclast differentiation mediated by Porphyromonas gingivalis sonicates in vitro.

  2003cites this paper
• Preventive effects of sequential treatment with alendronate and 1 alpha-hydroxyvitamin D3 on bone mass and strength in ovariectomized rats.

  2003influential citation
• Changes in markers of bone turnover and inflammatory variables during alendronate therapy in pediatric patients with rheumatic diseases.

  2002cites this paper
• Osteoporosis in childhood rheumatic diseases: prevention and therapy.

  2002cites this paper
• Cross-Linked C-Terminal Telopeptide of Type I Collagen in Serum before and after Treatment with Alfacalcidol and Calcium Carbonate in Early and Moderate Chronic Renal Failure

  2002cites this paper
• Bisphosphonate mechanism of action

  2002cites this paper
• Curative effect of combined treatment with alendronate and 1 alpha-hydroxyvitamin D3 on bone loss by ovariectomy in aged rats.

  2002cites this paper
• Chapter 78 – Bisphosphonates: Mechanisms of Action

  2002cites this paper
• Tissue culture models for studies of hormone and vitamin action in bone cells.

  2002cites this paper
• Development of a synthetic peptide-based tartrate-resistant acid phosphatase radioimmunoassay for the measurement of bone resorption in rat serum

  2002cites this paper
• Effect of topical alendronate on root resorption of dried replanted dog teeth.

  2001cites this paper
• Delayed Gastrointestinal Complications Associated with Alendronate: a Case Involving an Elderly Nursing Home Resident

  2001cites this paper
• Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro.

  2001cites this paper